As the market continues to climb, investors are beginning to see thinning dividend yields on many of their big pharma shares.
Keep Reading →
May 1 - Dividend Stocks, News
LONDON -- While crippling austerity in Europe and fiscal obstacles could put the brake on growth rates there, in developing regions a backdrop of accommodative central bank action...
Keep Reading →
May 1 - News
Dividend stocks can be a great addition to your portfolio, especially pharmaceutical dividend stocks that offer a bit of stability in rocky times.
Keep Reading →
May 1 - News
Would you hold a pharmaceutical product presentation in Hooters? That's just one of many alleged instances that the U.S.
Keep Reading →
May 1 - News
Big pharma is a controversial industry. Along with tobacco companies, they are some of the most vilified businesses in the world.
Keep Reading →
May 1 - News
In it's earnings call for last quarter, online retailer Amazon.com, Inc.
Keep Reading →
May 1 - News
Throughout the years, some of the best performing pharmaceutical industry stocks have had long histories of providing healthy dividends to their stockholders. Merck & Co., Inc...
Keep Reading →
April 30 - News
Patent expiration is one of the major issues faced by pharma companies, which increases the competition from generic medicines and eventually leads to downfall in their sales.
Keep Reading →
April 30 - News
One of the nice things about owning biotech companies is the large number of acquisitions in the sector.
Keep Reading →
April 30 - News
It’s not just about offering a better drug, but it’s also about launching it at the right time in the market.
Keep Reading →
April 28 - News
LONDON -- Back in January, I was looking to name (and shame) the five worst stocks on the FTSE 100 (INDEXFTSE:UKX), when my eyes alighted on GlaxoSmithKline plc (ADR) (GSK) (NYSE...
Keep Reading →
April 26 - News
Following in the footsteps of Abbott Laboratories (NYSE:ABT) spinning out its drug division into AbbVie Inc (NYSE:ABBV), and Pfizer spinning out its animal health division into...
Keep Reading →
April 26 - News
Editor's Note: Related Tickers: Amarin Corporation plc (ADR) (NASDAQ:AMRN), GlaxoSmithKline plc (ADR) (NYSE:GSK), Abbott Laboratories (NYSE:ABT), Valeant Pharmaceuticals Intl ...
Keep Reading →
April 23 - News
Northern Trust Corporation (NASDAQ:NTRS) FlexShares unit rolled out the International Quality Dividend Defensive Index Fund on Tuesday as part of a trio of new dividend ETFs with...
Keep Reading →
April 22 - Stock Analysis
With the SPDR S&P Biotech Index up 37% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
April 20 - News
Editor's Note: Related tickers: Theravance Inc (NASDAQ:THRX), GlaxoSmithKline plc (NYSE:GSK), Travelzoo Inc. (NASDAQ:TZOO), Arch Coal Inc (NYSE:ACI), Overstock.com, Inc.
Keep Reading →
April 18 - News
LONDON -- Next week is a busy week for news from FTSE 100 (INDEXFTSE:UKX) companies as first-quarter results time for those whose years end in December approaches -- and it ...
Keep Reading →
April 18 - News
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Keep Reading →
April 18 - News
So much for the big correction.
Keep Reading →
April 17 - News
There is always something interesting happening in the Bio-Pharma sector due to a number of firms working on several new drugs.
Keep Reading →
April 16 - News
Editor's Note: Related tickers: Theravance Inc (NASDAQ:THRX), VIVUS, Inc. (NASDAQ:VVUS), Amgen, Inc.
Keep Reading →
April 15 - News
I hope to pinpoint the very best buying opportunities in today's uncertain market, as well as highlight those shares I feel you should hold...
Keep Reading →
April 15 - News
Editor's Note: Related tickers: JPMorgan Chase & Co. (NYSE:JPM), Wells Fargo & Company (NYSE:WFC), Citigroup Inc.
Keep Reading →
April 15 - News
Earnings season is getting ready to rev into high gear, but earnings are unlikely to be the talk of the sector in the days to come, with three big Food and Drug Administration...
Keep Reading →
April 14 - News
The process of developing a drug from start to finish is incredibly arduous, usually involves around $1 billion in costs, and can take upwards of a decade to complete.
Keep Reading →
April 12 - News
LONDON -- After offering my pick of our telecom companies last week, today I'm turning my attention to the FTSE 100 Pharmaceuticals and Biotechnology sector.
Keep Reading →
April 12 - News
Looking for solid dividends? The health care sector has plenty of dividend stocks to choose from.
Keep Reading →
April 12 - News
LONDON -- The FTSE 100 has been off its highs for the past month, having set a new five-year record of 6,534 points on March 12.
Keep Reading →
April 11 - News
In this series I'm subjecting companies to scrutiny under five headings: prospects, performance, management, safety and valuation.
Keep Reading →
April 10 - News
The Dow Jones Industrial Average (Dow Jones Indices:.DJI) flashed a 60-point gain yesterday driven higher by the tech sector and its old dynamic duo, Microsoft Corporation (NASDAQ...
Keep Reading →
April 10 - News
Is AstraZeneca plc (ADR) (NYSE:AZN) worth your attention right now? The smart money is becoming less confident. The number of long hedge fund bets fell by 2 lately.
Keep Reading →
April 8 - News
Warren Buffett knows what he likes -- and he gets what he likes.
Keep Reading →
April 7 - News
April showers might bring May flowers, but the first week of the new month has already seen several health-care stocks hit full bloom.
Keep Reading →
April 7 - News
Before there was even a fancy term like "nicotine replacement therapy," the Swedish were using nicotine gum in the 1960s to help royal navy submariners manage their nicotine cravings...
Keep Reading →
April 7 - News
Abbott Laboratories (NYSE:ABT) has begun its new future swimmingly.
Keep Reading →
April 5 - News
There are many promising biotech companies out there to choose from. One such company, named Vical Incorporated (NASDAQ:VICL), is targeting a cancer known as Melanoma.
Keep Reading →
April 4 - News
As I noted five weeks ago, cancer statistics are both staggering and disappointing.
Keep Reading →
April 2 - News
AbbVie Inc (NYSE:ABBV) investors should be aware of an increase in hedge fund sentiment of late, and we'll compare the company to peers like GlaxoSmithKline plc (ADR) (NYSE:GSK...
Keep Reading →
April 2 - News
I haven't ever heard him say it directly, but it's pretty clear that Warren Buffett has no interest in buying biotech companies.
Keep Reading →
March 31 - Hedge Funds
LONDON -- Two scientists in white lab coats stare into a microscope.
Keep Reading →
March 26 - News
Every year, it appears that flu season starts earlier and earlier, and somehow, every year, the virus mutates into its "most virulent form ever." Sometimes it's a wonder we even...
Keep Reading →
March 25 - News
In this series, we'll highlight four companies in an industry, and compare their "cash king margins" over time, trying to determine which has the greatest likelihood of putting...
Keep Reading →
March 22 - News
It's not uncommon for me to applaud the pharmaceutical industry as a solid long-term investment.
Keep Reading →
March 19 - News
Bacteria have been Public Enemy No. 1 for most of our species' time on Earth.
Keep Reading →
March 18 - News
New issues in U.S. corporate bond markets topped $43 billion last week, with foreign-based borrowers taking down more than half the total.
Keep Reading →
March 18 - News
What doesn't J&J produce? From pharmaceuticals to consumer care goods to medical devices, this major medical player has it all.
Keep Reading →
March 18 - News
LONDON -- You have only a few weeks to use your ISA allowance before the April 5 deadline, so don't fluff this great tax-saving opportunity.
Keep Reading →
March 15 - News
Last year, a number of drugs received FDA approval.
Keep Reading →
March 14 - News
LONDON -- ISA season is upon us again! If you haven't yet used this year's 11,280 pound allowance for a stocks and stocks ISA, you only have a short time left before the April...
Keep Reading →
March 13 - News